SHANGHAI HILE BIO-TECHNOLOGY financial statements, including revenue, expenses, profit, and loss
The total revenue of 603718 for the last quarter is 66.00 M CNY, and it's 80.13% higher compared to the previous quarter. The net income of Q3 24 is 5.05 M CNY.